CG Oncology CGON Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by CG Oncology in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about CG Oncology's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CG Oncology's operating lease ROU assets?
- CG Oncology (CGON) reported operating lease ROU assets of $4.51M in Q1 2026.
- How has CG Oncology's operating lease ROU assets changed year-over-year?
- CG Oncology's operating lease ROU assets increased by 336.8% year-over-year, from $1.03M to $4.51M.
- What is the long-term trend for CG Oncology's operating lease ROU assets?
- Over 2 years (2023 to 2025), CG Oncology's operating lease ROU assets has grown at a 206.8% compound annual growth rate (CAGR), from $422K to $3.97M.
- What does operating lease ROU assets mean?
- This asset represents the company's right to use a leased item, such as office space or data center facilities, over the lease term. It is recognized under modern accounting standards to reflect the financial commitment of long-term operating leases. It provides visibility into the company's fixed operational footprint.